PD-1 Blockade in Anaplastic Thyroid CarcinomaJaume Capdevila, Matthew H. Taylor, Thomas Ernst et al.|Journal of Clinical Oncology|2020Cited by 349
Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational statusMartina Broecker‐Preuss, Dagmar Führer|BMC Cancer|2015Cited by 53
Dissecting Molecular Events in Thyroid Neoplasia Provides Evidence for Distinct Evolution of Follicular Thyroid Adenoma and CarcinomaKerstin Krause, Dagmar Führer|American Journal Of Pathology|2011Cited by 15